Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial - Concepedia

Concepedia

Publication | Open Access

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

DOI Full Paper Access

54

Citations

10

References

2016

Year

Sara Lonardi, Alberto Sobrero, Gerardo Rosati, Maria Di Bartolomeo, Monica Ronzoni, Giuseppe Aprile, Mario Scartozzi, Maria Banzi, Maria Giulia Zampino, Felice Pasini,

Annals of Oncology

Tosca TrialGastrointestinal OncologyMedicinePhase Iii TrialClinical TrialsPathologyColorectal CancerAdjuvant Folfox4/xeloxCancer TreatmentOncologyRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1